These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8300363)
1. Tissue plasminogen activator activity in human aqueous humor. Smalley DM; Fitzgerald JE; Taylor DM; Cone RE; O'Rourke J Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):48-53. PubMed ID: 8300363 [TBL] [Abstract][Full Text] [Related]
2. Increased basal levels of free plasminogen activator activity found in human aqueous humor. Wang Y; Taylor DM; Smalley DM; Cone RE; O'Rourke J Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3561-6. PubMed ID: 8056534 [TBL] [Abstract][Full Text] [Related]
3. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor]. Giedrojć J; Stankiewicz A; Walkowiak M; Galar M; Bielawiec M Klin Oczna; 1996; 98(4):283-5. PubMed ID: 9463119 [TBL] [Abstract][Full Text] [Related]
4. [Plasminogen activator and PAI. Detection in aqueous humor of the human eye]. Steinkamp GW; Hattenbach LO; Heider HW; Scharrer I Ophthalmologe; 1993 Feb; 90(1):73-5. PubMed ID: 8443455 [TBL] [Abstract][Full Text] [Related]
5. [Tissue plasminogen activator (t-PA) in aqueous humor of patients with cataract]. Kotschy M; Kałuzny J; Kaniasty M; Zekanowska E; Kropińska E Klin Oczna; 1996 Mar; 98(3):201-3. PubMed ID: 9019589 [TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor. Hayashi K; Nakashima Y; Sueishi K; Tanaka K Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726 [TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays. Camiolo SM; Greco WR Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257 [TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator in human aqueous humor. Bernatchez SF; Tabatabay C; Belin D Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2687-92. PubMed ID: 1639615 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431 [TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis. Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968 [TBL] [Abstract][Full Text] [Related]
11. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Declerck PJ; Verstreken M; Collen D Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114 [TBL] [Abstract][Full Text] [Related]
12. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females. Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623 [TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator: the identification of an additional proteinase at the outer acrosomal membrane of human and boar spermatozoa. Smokovitis A; Kokolis N; Taitzoglou I; Rekkas C Int J Fertil; 1992; 37(5):308-14. PubMed ID: 1358844 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA). Creighton-Kempsford LJ; Pring JB; Gaffney PJ Blood Coagul Fibrinolysis; 1992 Aug; 3(4):481-3. PubMed ID: 1420825 [TBL] [Abstract][Full Text] [Related]
16. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen activators in tissue extract of aural cholesteatoma. Nakamura M; Yamashiro Y; Nakahodo K; Sunagawa M; Huang GW; Kosugi T; Morimitsu T Laryngoscope; 1995 Mar; 105(3 Pt 1):305-10. PubMed ID: 7877421 [TBL] [Abstract][Full Text] [Related]
18. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes. Lijnen HR; Wagner EF; Collen D Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator. Kurokawa T; Iwasa S; Kakinuma A; Stassen JM; Lijnen HR; Collen D Thromb Haemost; 1991 Dec; 66(6):684-93. PubMed ID: 1796414 [TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Ganesh S; Sier CF; Griffioen G; Vloedgraven HJ; de Boer A; Welvaart K; van de Velde CJ; van Krieken JH; Verheijen JH; Lamers CB Cancer Res; 1994 Aug; 54(15):4065-71. PubMed ID: 8033138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]